Role of Receptors in the Metanephric Mesenchyme
Role of Receptors in the Metanephric Mesenchyme
批准号:
8496985
负责人:
CARLTON MATTHEW BATES
金额:
$34.45万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-04-01 至 2017-03-31
关键词:
ApoptosisBinding SitesBiological AssayCell Culture TechniquesCell PolarityCessation of lifeChildChronic Kidney FailureCongenital AbnormalityCystDataDefectDevelopmentDialysis procedureEmbryoEnd stage renal failureFetal KidneyFibroblast Growth Factor ReceptorsGene TargetingGrantHealth Care CostsKidneyKidney DiseasesKidney FailureKnock-outKnockout MiceLaboratoriesLinkMesenchymalMesenchymeMetanephric DiverticulumMolecularMorbidity - disease rateMorphogenesisMusMutant Strains MiceNephronsPatternPoint MutationPublicationsReceptor Protein-Tyrosine KinasesReceptor SignalingRegulationRoleSeriesSignal PathwaySignal TransductionStagingStem cellsStructureTestingTransgenic OrganismsTransplantationUnited StatesVesicleadapter proteinbasehuman FRS2 proteinmortalitymouse modelmutantnephrogenesisprematureprogenitorpublic health relevancereceptortreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Congenital kidney diseases are leading causes of chronic kidney disease in children. The application's broad long-term objectives are to understand molecular control of kidney development to make an impact on congenital kidney disease. Fibroblast growth factor receptors (Fgfrs) that signal through adapter proteins such as fibroblast growth factor receptor substrate 2¿ (Frs2¿) are critical for kidney development; however, global mouse gene targeting has not revealed the full impact of Fgfr or Frs2¿ signaling in fetal kidneys due to early lethality of the mutant embryos. Furthermore, conditional deletion of
Fgfr1 and Fgfr2 in the metanephric mesenchyme (MM) with a Pax3cre line led to renal dysgenesis. To elucidate roles of Fgfr/Frs2¿ signaling in the MM at later stages of renal development, compound mutants were generated with 1. Deletion of Fgfr1 in increasingly restricted and later stages of MM development and 2. Global point mutations in the Frs2¿ binding site in Fgfr2. The mutant mice with Fgfr1 deletion in early MM with the Pax3cre line and point mutations in the Frs2¿ binding site in Fgfr2 (PFLR mice), escape the renal dysgenesis seen with Pax3cre deletion of Fgfr1 and Fgfr2; however, PFLR mice developed ureteric bud (UB) branching defects, premature nephron progenitor (NP) depletion, and progressive cystogenesis in both ureteric and nephron lineages (showing importance of Frs2¿ directed signaling downstream of Fgfr2). The ureteric defects in PFLR mice start with dilated and hyper- proliferative UB tips that appear to be linked to inappropriate Ret signaling. The mice also appear to have defects in ciliary structure, canonical Wnt signaling, and planar cell polarity (PCP) that each may contribute to the developmental and cystic defects. Another set of mice, generated with a Six2cre line ("SFLR") that deletes Fgfr1 slightly later than PFLR and only in NPs (more restricted than PLFR) cause NP depletion and cysts from the nephron lineages, but have no apparent ureteric defects. SFLR NPs initially form normally, but appear to lose stem cell-like markers and undergo apoptosis. The third set of mice, generated with a Wnt4cre line ("WFLR") that delete in renal vesicles later than SFLR have no apparent renal abnormalities. The hypothesis is that spatial and temporal regulation of Fgfr signaling through Frs2¿ in the metanephric mesenchyme is critical for both ureteric and nephrogenic lineage patterning during development. To test the hypothesis, the following Aims were generated: Aim 1. To characterize the non-autonomous ureteric and autonomous nephrogenic lineage patterning defects in the allelic series of mutant mice. Embryonic and post-natal kidneys will be assessed for structural and functional defects. Aim 2. To determine mechanisms by which Fgfr/Frs2¿ signaling in kidney mesenchyme leads to ureteric morphogenesis defects and cystogenesis. Roles of the Bmp4/Ret/Erk axis and ciliary, canonical Wnt and PCP defects will be assessed. Aim 3: To determine mechanisms by which Fgfr/Frs2¿ signaling in kidney mesenchyme leads to premature nephron progenitor depletion. Candidate targets of Fgfr/Frs2¿ signaling identified by unbiased assays will assessed in NP cell cultures.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The University of Pittsburgh Summer Research Internship Program kidney workshop (SRIP-Kid)
-
批准号:10088062
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2021
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Role of Fgfr2 signaling in bladder injury and regeneration
-
批准号:9978050
-
项目类别:
-
资助金额:$23.21万
-
财政年份:2019
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Role of Fgfr2 signaling in bladder injury and regeneration
-
批准号:10187557
-
项目类别:
-
资助金额:$22.93万
-
财政年份:2019
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Critical Roles for Fibroblast Growth Factor Receptors in Bladder Development
-
批准号:8985305
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2015
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
The 13th International Workshop on Developmental Nephrology: From Basic Models to Translational Science
-
批准号:8908658
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2015
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
12th International Workshop on Developmental Nephrology
-
批准号:8517912
-
项目类别:
-
资助金额:$0.95万
-
财政年份:2013
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Role of Receptors in the Metanephric Mesenchyme
-
批准号:8640940
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2013
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Research Training in Pediatric Nephrology
-
批准号:8513986
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2011
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Research Training in Pediatric Nephrology
-
批准号:9070063
-
项目类别:
-
资助金额:$25.73万
-
财政年份:2011
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Research Training in Pediatric Nephrology
-
批准号:8290565
-
项目类别:
-
资助金额:$22.82万
-
财政年份:2011
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Research Training in Pediatric Nephrology
-
批准号:8703086
-
项目类别:
-
资助金额:$13.91万
-
财政年份:2011
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Research Training in Pediatric Nephrology
-
批准号:8073764
-
项目类别:
-
资助金额:$14.47万
-
财政年份:2011
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Research Training in Pediatric Nephrology
-
批准号:9306830
-
项目类别:
-
资助金额:$28.3万
-
财政年份:2011
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Model of Congenital Obstructive Nephropathy-Biomarker & Therapeutic Development
-
批准号:8420537
-
项目类别:
-
资助金额:$29.22万
-
财政年份:2010
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Model of Congenital Obstructive Nephropathy-Biomarker & Therapeutic Development
-
批准号:8265965
-
项目类别:
-
资助金额:$30.26万
-
财政年份:2010
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Model of Congenital Obstructive Nephropathy-Biomarker & Therapeutic Development
-
批准号:7770174
-
项目类别:
-
资助金额:$37.9万
-
财政年份:2010
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Model of Congenital Obstructive Nephropathy-Biomarker & Therapeutic Development
-
批准号:8037048
-
项目类别:
-
资助金额:$30.25万
-
财政年份:2010
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
Model of Congenital Obstructive Nephropathy-Biomarker & Therapeutic Development
-
批准号:8618897
-
项目类别:
-
资助金额:$30.29万
-
财政年份:2010
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
A genetic model of vesicoureteral reflux and reflux nephropathy
-
批准号:8286408
-
项目类别:
-
资助金额:$33.27万
-
财政年份:2009
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
A genetic model of vesicoureteral reflux and reflux nephropathy
-
批准号:7577263
-
项目类别:
-
资助金额:$38.28万
-
财政年份:2009
-
负责人:CARLTON MATTHEW BATES
-
依托单位:
海外基金